Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,346 | 140 | 99.5% |
| Education | $11.71 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $615.30 | 45 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $324.66 | 20 | $0 (2024) |
| Novo Nordisk Inc | $322.54 | 16 | $0 (2024) |
| Abbott Laboratories | $191.05 | 12 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $110.24 | 6 | $0 (2021) |
| Astellas Pharma US Inc | $107.38 | 6 | $0 (2024) |
| Amgen Inc. | $105.25 | 5 | $0 (2023) |
| ABBVIE INC. | $100.08 | 5 | $0 (2024) |
| Lilly USA, LLC | $92.02 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $76.31 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $228.05 | 12 | Novo Nordisk Inc ($63.86) |
| 2023 | $765.46 | 44 | GlaxoSmithKline, LLC. ($175.50) |
| 2022 | $381.23 | 30 | GlaxoSmithKline, LLC. ($181.70) |
| 2021 | $420.67 | 25 | GlaxoSmithKline, LLC. ($119.66) |
| 2020 | $335.17 | 17 | GlaxoSmithKline, LLC. ($78.58) |
| 2019 | $227.23 | 13 | AstraZeneca Pharmaceuticals LP ($64.85) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Obesity | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Respiratory | ||||||
| 07/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.89 | General |
| 06/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Respiratory | ||||||
| 04/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: RESPIRATORY | ||||||
| 04/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Diabetes Care | ||||||
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: RESPIRATORY | ||||||
| 03/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Biological | ||||||
| 02/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Obesity | ||||||
| 12/19/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: VACCINES | ||||||
| 12/07/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/28/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: VACCINES | ||||||
| 11/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/08/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Diabetes Care | ||||||
| 11/07/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: VACCINES | ||||||
| 10/12/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/11/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Diabetes | ||||||
| 10/09/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: VACCINES | ||||||
| 10/05/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Inflammation | ||||||
| 09/19/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: RESPIRATORY | ||||||
| 09/13/2023 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug), CONTRAVE, NEXLETOL | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 614 | 952 | $172,201 | $59,896 |
| 2022 | 12 | 408 | 547 | $89,209 | $24,241 |
| 2021 | 6 | 240 | 394 | $48,151 | $27,759 |
| 2020 | 6 | 193 | 284 | $28,994 | $14,466 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 194 | $61,210 | $22,805 | 37.3% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 40 | 94 | $21,999 | $11,518 | 52.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 92 | $32,697 | $7,481 | 22.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 44 | 44 | $12,501 | $6,555 | 52.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 46 | $6,616 | $2,131 | 32.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $3,818 | $1,982 | 51.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 104 | 211 | $4,261 | $1,772 | 41.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $6,141 | $1,705 | 27.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $4,825 | $1,267 | 26.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 44 | 47 | $2,613 | $631.12 | 24.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 27 | $1,378 | $463.14 | 33.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 19 | 21 | $2,349 | $310.38 | 13.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 21 | 22 | $3,710 | $288.64 | 7.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 27 | 32 | $1,871 | $265.28 | 14.2% |
| 80076 | Liver function blood test panel | Office | 2023 | 26 | 29 | $1,270 | $232.29 | 18.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 25 | 27 | $1,455 | $205.47 | 14.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 15 | $1,188 | $142.80 | 12.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 15 | 16 | $2,298 | $141.44 | 6.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 123 | $38,683 | $12,636 | 32.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 34 | 34 | $13,833 | $4,875 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 49 | $16,875 | $3,910 | 23.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 35 | 35 | $3,773 | $443.09 | 11.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 77 | 140 | $3,085 | $414.63 | 13.4% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2022 | 24 | 27 | $2,547 | $400.86 | 15.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 14 | 16 | $1,146 | $332.98 | 29.1% |
About Dr. Sharda Ramsaroop, MD
Dr. Sharda Ramsaroop, MD is a Geriatric Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043290208.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sharda Ramsaroop, MD has received a total of $2,358 in payments from pharmaceutical and medical device companies, with $228.05 received in 2024. These payments were reported across 141 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,346).
As a Medicare-enrolled provider, Ramsaroop has provided services to 1,455 Medicare beneficiaries, totaling 2,177 services with total Medicare billing of $126,363. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Geriatric Medicine
- Location New York, NY
- Active Since 01/21/2006
- Last Updated 11/28/2011
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1043290208
Products in Payments
- TRELEGY ELLIPTA (Drug) $553.11
- FARXIGA (Drug) $253.04
- FREESTYLE LIBRE 3 (Device) $131.94
- Wegovy (Drug) $124.88
- JANUVIA (Drug) $90.98
- XARELTO (Drug) $76.31
- QULIPTA (Drug) $62.37
- MOUNJARO (Drug) $60.06
- Veozah (Drug) $54.40
- MYRBETRIQ (Drug) $52.98
- SHINGRIX (Biological) $49.09
- TRADJENTA (Drug) $47.99
- Rybelsus (Drug) $46.18
- INJECTAFER (Drug) $45.59
- Otezla (Drug) $45.13
- BREZTRI (Drug) $44.78
- Ozempic (Drug) $43.79
- APTIMA (Device) $37.50
- EVENITY (Biological) $34.53
- Aimovig (Biological) $25.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in New York
Dr. Howard Fillit, Md, MD
Geriatric Medicine — Payments: $64,263
Lisa Babitz, Md, MD
Geriatric Medicine — Payments: $7,071
Dr. Kenneth Mercer, Md Mph, MD MPH
Geriatric Medicine — Payments: $4,806
Laleh Moazen, M.d, M.D
Geriatric Medicine — Payments: $4,667
Laszlo Feher, Do, DO
Geriatric Medicine — Payments: $4,640
John Getsos, M.d, M.D
Geriatric Medicine — Payments: $3,449